While GBM tumors display profound intercellular heterogeneity that is dynamic, almost all GBM cells express key drivers of the mesenchymal phenotype, such as MMP2, SNAI2, YKL-40 (CHI3L1), and ZEB1 [5,6,7,8]. This evidence concerns the gene SNAI2 and glioblastoma.